Her Zhisheng, Tan Joel Heng Loong, Lim Yee-Siang, Tan Sue Yee, Chan Xue Ying, Tan Wilson Wei Sheng, Liu Min, Yong Kylie Su Mei, Lai Fritz, Ceccarello Erica, Zheng Zhiqiang, Fan Yong, Chang Kenneth Tou En, Sun Lei, Chang Shih Chieh, Chin Chih-Liang, Lee Guan Huei, Dan Yock Young, Chan Yun-Shen, Lim Seng Gee, Chan Jerry Kok Yen, Chandy K George, Chen Qingfeng
Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.
Genome Institute of Singapore, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.
Front Immunol. 2020 Sep 11;11:580968. doi: 10.3389/fimmu.2020.580968. eCollection 2020.
Non-alcoholic fatty liver disease (NAFLD) has been on a global rise. While animal models have rendered valuable insights to the pathogenesis of NAFLD, discrepancy with patient data still exists. Since non-alcoholic steatohepatitis (NASH) involves chronic inflammation, and CD4 T cell infiltration of the liver is characteristic of NASH patients, we established and characterized a humanized mouse model to identify human-specific immune response(s) associated with NAFLD progression. Immunodeficient mice engrafted with human immune cells (HIL mice) were fed with high fat and high calorie (HFHC) or chow diet for 20 weeks. Liver histology and immune profile of HIL mice were analyzed and compared with patient data. HIL mice on HFHC diet developed steatosis, inflammation and fibrosis of the liver. Human CD4 central and effector memory T cells increased within the liver and in the peripheral blood of our HIL mice, accompanied by marked up-regulation of pro-inflammatory cytokines (IL-17A and IFNγ). depletion of human CD4 T cells in HIL mice reduced liver inflammation and fibrosis, but not steatosis. Our results highlight CD4 memory T cell subsets as important drivers of NAFLD progression from steatosis to fibrosis and provides a humanized mouse model for pre-clinical evaluation of potential therapeutics.
非酒精性脂肪性肝病(NAFLD)在全球范围内呈上升趋势。虽然动物模型为NAFLD的发病机制提供了有价值的见解,但与患者数据仍存在差异。由于非酒精性脂肪性肝炎(NASH)涉及慢性炎症,且肝脏中CD4 T细胞浸润是NASH患者的特征,我们建立并表征了一种人源化小鼠模型,以确定与NAFLD进展相关的人类特异性免疫反应。将人免疫细胞植入免疫缺陷小鼠(HIL小鼠),并给予高脂高糖(HFHC)或普通饮食20周。分析HIL小鼠的肝脏组织学和免疫特征,并与患者数据进行比较。接受HFHC饮食的HIL小鼠出现肝脏脂肪变性、炎症和纤维化。我们的HIL小鼠肝脏和外周血中的人CD4中央记忆和效应记忆T细胞增加,同时促炎细胞因子(IL-17A和IFNγ)显著上调。在HIL小鼠中耗竭人CD4 T细胞可减轻肝脏炎症和纤维化,但不能减轻脂肪变性。我们的结果突出了CD4记忆T细胞亚群是NAFLD从脂肪变性进展为纤维化的重要驱动因素,并为潜在治疗药物的临床前评估提供了一种人源化小鼠模型。